- Home
- COE vs TLPH Comparison
COE vs TLPH Comparison
Compare COE & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COE | TLPH |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.1M | 70.3M |
| IPO Year | 2015 | 2010 |
Fundamental Metrics
Financial Performance| Metric | COE | TLPH |
|---|---|---|
| Price | $11.46 | $1.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $3.13 |
| AVG Volume (30 Days) | 26.0K | ★ 119.7K |
| Earning Date | 12-07-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,151,000.00 |
| Revenue This Year | $70.66 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.93 | $0.69 |
| 52 Week High | $52.00 | $1.57 |
Technical Indicators
Market Signals| Indicator | COE | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 48.92 | 42.64 |
| Support Level | $9.95 | $1.03 |
| Resistance Level | $12.48 | $1.14 |
| Average True Range (ATR) | 0.84 | 0.04 |
| MACD | 0.22 | 0.00 |
| Stochastic Oscillator | 68.34 | 33.33 |
Price Performance
Historical ComparisonAbout COE 51Talk Online Education Group
51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in geographical areas: Asia-Pacific region; and Other areas, of which it derives maximum revenue from Asia-Pacific.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.